Figure S3 from IL15 Infusion of Cancer Patients Expands the Subpopulation of Cytotoxic CD56bright NK Cells and Increases NK-Cell Cytokine Release Capabilities
posted on 2023-04-03, 23:05authored bySigrid Dubois, Kevin C. Conlon, Jürgen R. Müller, Jennifer Hsu-Albert, Nancy Beltran, Bonita R. Bryant, Thomas A. Waldmann
Example of cytotoxicity assay. NK cell subsets were sorted by FACS. Control RAJI and target K562 cells were labeled with different CFSE concentrations, mixed and exposed to sorted NK cells for 18 hours. We determined the relative survival of control vs. target cells by FACS.